How the stock market's big turnaround on Monday put the S&P 500 back in record territory
marketwatch.com
Want to monitor NTLA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor NTLAintellia therapeutic’s core mission is to develop curative medicines, utilizing the promise of the crispr/cas9 gene editing technology. the development of crispr/cas9 gene editing technology opens a new frontier in biomedical research and clinical intervention. adapted from a natural cellular process, crispr/cas9 permits the editing of any gene in any organism with unprecedented simplicity and flexibility.